Tag: Prescription Drugs
One in Five With Opioid Use Disorder Receive Medications
Medications for OUD more likely for those with severe versus mild past-year OUD, receiving substance use treatment via telehealth
Wegovy Lowered Users’ Heart Risks in New Trial
Clinical trial demonstrates reduction in major adverse cardiovascular events of 20 percent, drug maker says
Generic, Brand-Name Medication Similarly Effective for COPD
Wixela Inhub and Advair Diskus fluticasone-salmeterol are similarly effective and safe for COPD
High-Dose VX-548 Reduces Acute Pain Over 48 Hours
Study shows reduction in acute pain for high- but not low-dose VX-548
Glycemic Control Superior With Semaglutide 25 and 50 mg in Type 2 Diabetes
Mean changes in HbA1c significantly greater for semaglutide 25 mg or 50 mg versus 14 mg
Study Cannot Exclude Benefit of Progesterone for Vasomotor Symptoms
Women perceived that progesterone caused a reduction in night sweats and improved sleep quality
FDA Approves Second OTC Naloxone Spray for Suspected Opioid Overdose
The American Medical Association applauded the approval to improve access to nonprescription naloxone as a way to curb the opioid epidemic
Lawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’
Lawsuit alleges drugmakers failed to adequately warn patients about the risk for severe stomach problems
Higher Belly Fat Percentage Tied to Worse Outcomes for IBD Patients
Patients with higher intra-abdominal visceral adipose tissue percentage less likely to achieve corticosteroid-free deep remission or endoscopic remission
Oral Probenecid Cuts Time to Viral Clearance in COVID-19
Median time to viral clearance was significantly shorter for 500, 1,000 mg probenecid versus placebo